GI Pharmacology Course
Course Co-Directors: Brooks D. Cash, MD, FACG, and William D. Chey, MD, FACG
Experts define and describe the use and management of new pharmacological therapies as well as updates in current pharmacological treatment options for a variety of GI disorders during ACG's What’s New in GI Pharmacology Course.
The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Gastroenterology designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.25 MOC points in the ABIM’s MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
How to Claim CME and MOC:
Complete the online evaluation at the ACG website, www.evals.gi.org/am/2019, to claim CME credit commensurate with your participation in the course (the evaluation site for this course will open on Friday, October 25, 2019). Please complete your CME evaluation and MOC assessment soon after the course. ABIM Board Certified physicians need to complete the MOC assessment by December 31, 2019 in order for the MOC points to count toward any MOC requirements that are due by the end of the year. No MOC credit may be awarded for this activity after March 1, 2020.
Instructions on how to claim CME and MOC will be available in the Event Resources tile of the meeting app.